News by Tag: Indian Diagnostic Market
Evaluate Strategies to Launch Monoclonal Antibodies in India
June 26, 2012
IMARC Group's new report will enable you to gain a comprehensive understanding of the Indian diagnostic and therapeutic antibodies market
June 26, 2012
IMARC Group's new report will enable you to gain a comprehensive understanding of the Indian diagnostic and therapeutic antibodies market
Most of the Marketed Monoclonal Antibodies Lack a Patent Protection in India
January 25, 2012
Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India.
January 25, 2012
Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India.
IMARC Releases the Most Robust Analysis on the Indian Diagnostic & Therapeutic Antibodies Market
January 19, 2012
A new report from IMARC Group finds that the Indian market for both diagnostic and therapeutic antibodies is expected to grow exponentially in the coming years.
January 19, 2012
A new report from IMARC Group finds that the Indian market for both diagnostic and therapeutic antibodies is expected to grow exponentially in the coming years.
Indian Diagnostics Market Heading for Magnificent Growth
March 14, 2011
Indian Diagnostics market is projected to grow at a magnificent growth rate of 22% during 2010-2012, says the latest report from RNCOS.
March 14, 2011
Indian Diagnostics market is projected to grow at a magnificent growth rate of 22% during 2010-2012, says the latest report from RNCOS.
Indian Diagnostic Market Set for Stupendous Growth
January 10, 2011
The Indian diagnostics market is expected to grow at a stupendous growth rate of around 22% during 2010 - 2012, says a new report from RNCOS.
January 10, 2011
The Indian diagnostics market is expected to grow at a stupendous growth rate of around 22% during 2010 - 2012, says a new report from RNCOS.